Management of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection

Aim. To study the effectiveness of acyclovir in patients with systemic autoimmune diseases caused by active chronic herpes simplex 1/2 infection. Material and Methods. Among 380 patients with systemic autoimmune diseases (systemic lupus erythematosus, systemic vasculitis, rheumatoid arthritis, ps...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	I.G. Gaiduchok, Kh.O. Lishchuk-Yakymovych
Formato:	article
Lenguaje:	EN UK
Publicado:	Danylo Halytsky Lviv National Medical University 2020
Materias:	systemic autoimmune diseases, herpes simplex viruses, antiviral therapy Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/b5d8f0a18bc04502b7c1dc40f0bea1c2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b5d8f0a18bc04502b7c1dc40f0bea1c2
record_format	dspace
spelling	oai:doaj.org-article:b5d8f0a18bc04502b7c1dc40f0bea1c22021-11-10T19:49:51ZManagement of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection1029-42442415-330310.25040/aml2020.02-03.021https://doaj.org/article/b5d8f0a18bc04502b7c1dc40f0bea1c22020-09-01T00:00:00Zhttps://amljournal.com/index.php/journal/article/view/21https://doaj.org/toc/1029-4244https://doaj.org/toc/2415-3303Aim. To study the effectiveness of acyclovir in patients with systemic autoimmune diseases caused by active chronic herpes simplex 1/2 infection. Material and Methods. Among 380 patients with systemic autoimmune diseases (systemic lupus erythematosus, systemic vasculitis, rheumatoid arthritis, psoriasis) in 45 (11.8%) patients was diagnosed active phase of chronic HSV1/2 infection with help of viral DNA identification by polymerase chain reaction. These patients received acyclovir in three courses with a one-month interval between them. The effectiveness of treatment was monitored before and after treatment with help of virus DNA results in three bioenvironments (blood, saliva and swab from the lesion), of general and specific IgM, IgG antibodies concentration; levels of IgE, cryoglobulins, circulating immune complexes, alpha-interferon, C3-component of complement, the number of lymphocytes populations/subpopulations and of activated cells. Results and Discussion. After the treatment, it was fixed as significant decrease of specific IgM, IgG antibodies concentration as of the level of total IgE, cryoglobulins and cryofibrinogen. In addition it was observed as significant decreased level of alpha-interferon in the serum and saliva, as of the natural killers and number of lymphocytes, expressing the low-affinity receptor IL2 (CD25+) and lymphocytes with suppressive activity (CD4+25+). After the treatment it was observed by polymerase chain reaction a decrease of virus replication in 66.7% of cases. Conclusions. The results of the study indicate, that the use of acyclovir for the treatment of active phase of chronic HSV 1/2-infection might contribute as to the decrease in the virus replication, reducing the viral load, as to the suppression of aggressive autoimmune reactions, reducing the risk of allergopathology development.I.G. GaiduchokKh.O. Lishchuk-YakymovychDanylo Halytsky Lviv National Medical Universityarticlesystemic autoimmune diseases, herpes simplex viruses, antiviral therapyMedicine (General)R5-920ENUKActa Medica Leopoliensia, Vol 26, Iss 2-3, Pp 21-27 (2020)
institution	DOAJ
collection	DOAJ
language	EN UK
topic	systemic autoimmune diseases, herpes simplex viruses, antiviral therapy Medicine (General) R5-920
spellingShingle	systemic autoimmune diseases, herpes simplex viruses, antiviral therapy Medicine (General) R5-920 I.G. Gaiduchok Kh.O. Lishchuk-Yakymovych Management of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection
description	Aim. To study the effectiveness of acyclovir in patients with systemic autoimmune diseases caused by active chronic herpes simplex 1/2 infection. Material and Methods. Among 380 patients with systemic autoimmune diseases (systemic lupus erythematosus, systemic vasculitis, rheumatoid arthritis, psoriasis) in 45 (11.8%) patients was diagnosed active phase of chronic HSV1/2 infection with help of viral DNA identification by polymerase chain reaction. These patients received acyclovir in three courses with a one-month interval between them. The effectiveness of treatment was monitored before and after treatment with help of virus DNA results in three bioenvironments (blood, saliva and swab from the lesion), of general and specific IgM, IgG antibodies concentration; levels of IgE, cryoglobulins, circulating immune complexes, alpha-interferon, C3-component of complement, the number of lymphocytes populations/subpopulations and of activated cells. Results and Discussion. After the treatment, it was fixed as significant decrease of specific IgM, IgG antibodies concentration as of the level of total IgE, cryoglobulins and cryofibrinogen. In addition it was observed as significant decreased level of alpha-interferon in the serum and saliva, as of the natural killers and number of lymphocytes, expressing the low-affinity receptor IL2 (CD25+) and lymphocytes with suppressive activity (CD4+25+). After the treatment it was observed by polymerase chain reaction a decrease of virus replication in 66.7% of cases. Conclusions. The results of the study indicate, that the use of acyclovir for the treatment of active phase of chronic HSV 1/2-infection might contribute as to the decrease in the virus replication, reducing the viral load, as to the suppression of aggressive autoimmune reactions, reducing the risk of allergopathology development.
format	article
author	I.G. Gaiduchok Kh.O. Lishchuk-Yakymovych
author_facet	I.G. Gaiduchok Kh.O. Lishchuk-Yakymovych
author_sort	I.G. Gaiduchok
title	Management of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection
title_short	Management of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection
title_full	Management of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection
title_fullStr	Management of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection
title_full_unstemmed	Management of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection
title_sort	management of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection
publisher	Danylo Halytsky Lviv National Medical University
publishDate	2020
url	https://doaj.org/article/b5d8f0a18bc04502b7c1dc40f0bea1c2
work_keys_str_mv	AT iggaiduchok managementofpatientswithsystemicautoimmunediseaseswiththeactivephaseofchronicherpessimplexinfection AT kholishchukyakymovych managementofpatientswithsystemicautoimmunediseaseswiththeactivephaseofchronicherpessimplexinfection
_version_	1718439712014729216

Management of patients with systemic autoimmune diseases with the active phase of chronic herpes simplex infection

Ejemplares similares